Nurix Therapeutics, Inc. (NASDAQ:NRIX) IPO
IPO
Priced at US$19.00 a share on Jul 23, 2020.
- Price
- US$19.00 a share
- Shares offered
- 11,000,000 shares of common stock
- Offering size
- US$209 million
- Underwriters' option
- Up to 1,650,000 more shares
- Underwriters
- J.P. Morgan, Piper Sandler, Stifel, Needham & Company · In the order on the cover
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | May 5, 2020 |
| Filed publicly | Jul 2, 2020 |
| Amended twice | Newest Jul 23, 2020 |
| Shares registered with an exchange | Jul 20, 2020 |
| Declared effective by the SEC | Jul 23, 2020 |
| Final prospectus, with the price | Jul 24, 2020 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Jul 24, 2020 |
| EFFECT · Notice that a registration is effective | Jul 23, 2020 |
| CERT · Exchange's certificate of listing | Jul 23, 2020 |
| S-1/A · Registration statement, amended | Jul 23, 2020 |
| CORRESP · Letter to the SEC | Jul 21, 2020 |
| CORRESP · Letter to the SEC | Jul 21, 2020 |
| 8-A12B · Registration of shares for listing on an exchange | Jul 20, 2020 |
| S-1/A · Registration statement, amended | Jul 20, 2020 |
| CORRESP · Letter to the SEC | Jul 10, 2020 |
| S-1 · Registration statement | Jul 2, 2020 |
| DRSLTR · Letter to the SEC with a draft | Jun 10, 2020 |
| DRS/A · Draft registration statement, amended | Jun 10, 2020 |
| UPLOAD · Letter from the SEC | Jun 4, 2020 |
| DRS · Draft registration statement | May 5, 2020 |
From the cover of the final prospectus (424B4) filed Jul 24, 2020